The New PAMA Math:
Laboratory Data Key to Overcoming Medicare Cuts
This white paper was developed in collaboration with Mayo Clinic and is based on a panel discussion from the 2019 Dark Report Executive War College benefactor session featuring speakers from Change Healthcare and Mayo Clinic. As significant as the PAMA cuts are, their financial impact extends beyond Medicare payments. Many commercial payers and state Medicaid programs base their reimbursement on Medicare rates. That means most lab revenues will be driven lower over time. PAMA’s financial impact comes at a time when hospital laboratories are already under intense margin pressure. As a result, a growing number of laboratory and hospital leaders are seeking alternative solutions that enable the fee-for-service laboratory to continue operating as a vital and sustainable service line within the hospital.
- Learn about three cutting-edge ways in which data is being utilized to overcome the PAMA impact.
- Use PAMA to transform operations and standing within the hospital.
- Develop an optimization plan starts with data mining to understand both weaknesses and areas of opportunity.
- Invest resources that capitalize on and demonstrate the lab’s value as part of the transition to value-based care.
Download the Whitepaper
You May Also Be Interested In
Enable the laboratory to drive the transition to high-value care.
Patient Blood Management
Learn about our complete Patient Blood Management solution.
Reduce care variation, improve order appropriateness, and comply with important federal legislation.
Align with Choosing Wisely, an initiative of the ABIM Foundation, to cover high impact medications, procedures, and screenings.